1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBreakthrough T1D Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies RFA Grant is sponsored by Breakthrough T1D. Funds research to enhance the efficiency of protocols and address barriers to implementing next-generation beta cell replacement therapies for type 1 diabetes.
Get alerted about grants like this
Get emailed when new opportunities from “Breakthrough T1D” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Academic and industry partners. Confirm the full requirements in the official notice before applying.
The current listing shows up to $600,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Breakthrough T1D Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies RFA Grant is funded by Breakthrough T1D. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Mental Health and T1D Community Grants is sponsored by Breakthrough T1D Canada. Mental Health and T1D Community Grants is a seed-funding initiative from Breakthrough T1D Canada that supports organizations developing innovative projects to improve the mental health and wellness of people living with Type 1 diabetes and their informal caregivers.
FY27 Training Awards (human subject research on long-term complications, specifically diabetic eye, kidney, and cardiovascular disease) is sponsored by Breakthrough T1D (formerly Juvenile Diabetes Research Foundation International - JDRFI). These training awards are for applicants proposing human subject research on long-term complications of Type 1 Diabetes, including diabetic eye disease, that align with Breakthrough T1D's research strategy.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleNIH's FY2026 omnibus adds a Phase IIB Strategic Breakthrough Award up to $30M — but it requires a 100% outside match. Here's who it's for and how to plan.
Read articleNSF's rebuilt SBIR/STTR program (NSF 26-510) pairs a $305,000 Phase I with a brand-new Strategic Breakthrough award worth up to $30 million for the strongest Phase II companies. The next Project Pitch deadline is July 27, 2026. Here is how the non-dilutive funding ladder now works, why the Project Pitch gate decides everything, and how a founder should sequence the next twelve months.
Read article